Korean Medication Algorithm Project for Bipolar Disorder 2018 (KMAP-BP 2018): Fourth Revision

키워드

참고문헌 (63)

1. Parker GB, "Is there consensus across international evidence-based guidelines for the management of bipolar disorder?", Acta Psychiatr Scand, 135, pp.515~526 (2017)
2. 박원명, "양극성 장애의 한국형 약물치료 알고리듬", 대한정신약물학회지, 13(3), pp.205~221 (2002), 대한정신약물학회
3. 김찬형, "한국형 양극성 장애 약물치료 알고리듬의 적용 가능성(Ⅰ)：전반적 평가", 대한정신약물학회지, 16(3), pp.225~233 (2005), 대한정신약물학회
4. 신영철, "한국형 양극성 장애 약물치료 알고리듬의 적용 가능성(Ⅱ)：약물의 선택", 대한정신약물학회지, 16(4), pp.285~291 (2005), 대한정신약물학회
5. 전덕인, "한국형 양극성 장애 약물치료 알고리듬의 적용 가능성(Ⅲ)：치료반응과 내약성", 대한정신약물학회지, 16(4), pp.292~300 (2005), 대한정신약물학회
6. Jeong Seok Seo, "Korean Medication Algorithm for Depressive Disorders 2017: Third Revision", Clinical Psychopharmacology and Neuroscience, 16(1), pp.67~87 (2018), 대한정신약물학회[DOI]
7. Hee Ryung Wang, "Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines", Clinical Psychopharmacology and Neuroscience, 15(3), pp.199~209 (2017), 대한정신약물학회[DOI]
8. Jon DI, "Revised Korean Medication Algorithm for Bipolar Disorder", World J Biol Psychiatry, 10, pp.846~855 (2009)
9. Shin YC, "Korean Medication Algorithm for Bipolar Disorder: second revision", Asia Pac Psychiatry, 5, pp.301~308 (2013)
10. Woo YS, "Korean Medication Algorithm Project for Bipolar Disorder:third revision", Neuropsychiatr Dis Treat, 11, pp.493~506 (2015)
11. American Psychiatric Association, "Diagnostic and statistical manual of mental disorders" (2013), American Psychiatric Association
12. Sachs GS, "The Expert Consensus Guideline Series: medication treatment of bipolar disorder 2000", Postgrad Med, pp.1~104 (2000)
13. Grunze H, "The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania", World J Biol Psychiatry, 10, pp.85~116 (2009)
14. Yatham LN, "Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013", Bipolar Disord, 15, pp.1~44 (2013)
15. Lin D, "Polytherapy in bipolar disorder", CNS Drugs, 20, pp.29~42 (2006)
16. Ketter TA, "Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder", J Clin Psychiatry, 69(Suppl 5), pp.9~15 (2008)
17. Bourin MS, "Lithium as add-on to quetiapine XR in adult patients with acute mania: a 6-week, multicenter, double-blind, randomized, placebo-controlled study", Int J Bipolar Disord, 2, pp.14~ (2014)
18. Xu L, "Olanzapine-valproate combination versus olanzapine or valproate monotherapy in the treatment of bipolar I mania: a randomized controlled study in a Chinese population group", Neuropsychiatr Dis Treat, 11, pp.1265~1271 (2015)
19. Ogawa Y, "Mood stabilizers and antipsychotics for acute mania: a systematic review and meta-analysis of combination", augmentation therapy versus monotherapy, 2014, pp.28, 989~1003
20. Levin JB, "Medication adherence in patients with bipolar disorder: a comprehensive review", CNS Drugs, 30, pp.819~835 (2016)
21. Leclerc E, "Determinants of adherence to treatment in bipolar disorder: a comprehensive review", J Affect Disord, 149, pp.247~252 (2013)
22. Galling B, "Safety and tolerability of antipsychotic-mood stabilizer co-treatment in the management of acute bipolar disorder: results from a systematic review and exploratory meta-analysis", Expert Opin Drug Saf, 14, pp.1181~1199 (2015)
23. Cipriani A, "Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis", Lancet, 378, pp.1306~1315 (2011)
24. Yatham LN, "Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder", Bipolar Disord, 20, pp.97~170 (2018)
25. Fountoulakis KN, "The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 3: the clinical guidelines", Int J Neuropsychopharmacol, 20, pp.180~195 (2017)
26. Lindström L, "Maintenance therapy with second generation antipsychotics for bipolar disorder - A systematic review and meta-analysis", J Affect Disord, 213, pp.138~150 (2017)
27. Grunze H, "The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder", World J Biol Psychiatry, 14, pp.154~219 (2013)
28. Calabrese JR, "Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials", Bipolar Disord, 10, pp.323~333 (2008)
29. Unholzer S, "Retrospective analysis of therapeutic drug monitoring data for treatment of bipolar disorder with Lamotrigine", Pharmacopsychiatry, 48, pp.296~ (2015)
30. Solmi M, "Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials", CNS Spectr, 21, pp.403~418 (2016)
31. National Collaborating Centre for Mental Health (UK), "Bipolar disorder: the assessment and management of bipolar disorder in adults, children and young people in primary and secondary care, revised version" (2014), British Psychological Society
32. Goodwin GM, "Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology", J Psychopharmacol, 30, pp.495~553 (2016)
33. Vieta E, "Antidepressants in bipolar I disorder: never as monotherapy", Am J Psychiatry, 171, pp.1023~1026 (2014)
34. In Hee Shim, "Predictors of a Shorter Time to Hospitalization in Patients with Bipolar Disorder: Medication during the Acute and Maintenance Phases and Other Clinical Factors", Clinical Psychopharmacology and Neuroscience, 15(3), pp.248~255 (2017), 대한정신약물학회[DOI]
35. Vázquez GH, "Overview of antidepressant treatment of bipolar depression", Int J Neuropsychopharmacol, 16, pp.1673~1685 (2013)
36. Fountoulakis KN, "The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, grading of the evidence, and a precise algorithm", Int J Neuropsychopharmacol, 20, pp.121~179 (2017)
37. Cruz N, "Efficacy of modern antipsychotics in placebo-con trolled trials in bipolar depression: a meta-analysis", Int J Neuropsychopharmacol, 13, pp.5~14 (2010)
38. Sanford M, "Quetiapine: a review of its use in the management of bipolar depression", CNS Drugs, 26, pp.435~460 (2012)
39. Yatham LN, "A clinical review of Aripiprazole in bipolar depression and maintenance therapy of bipolar disorder", J Affect Disord, 128(Suppl 1), pp.S21~S28 (2011)
40. Thase ME, "Aripiprazole in bipolar depression: a pooled, post-hoc analysis by severity of core depressive symptoms", Int J Psychiatry Clin Pract, 16, pp.121~131 (2012)
41. Fountoulakis KN, "Aripiprazole monotherapy in the treatment of bipolar disorder: a meta-analysis", J Affect Disord, 133, pp.361~370 (2011)
42. Young Sup Woo, "Dose Trends of Aripiprazole from 2004 to 2014 in Psychiatric Inpatients in Korea", Clinical Psychopharmacology and Neuroscience, 15(2), pp.177~180 (2017), 대한정신약물학회[DOI]
43. Ather Muneer, "Mixed States in Bipolar Disorder: Etiology, Pathogenesis and Treatment", 전남의대학술지, 53(1), pp.1~13 (2017), 의과학연구소
44. Weisler RH, "Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials", CNS Drugs, 20, pp.219~231 (2006)
45. Stahl S, "Efficacy of ziprasidone in dysphoric mania: pooled analysis of two double-blind studies", J Affect Disord, 122, pp.39~45 (2010)
46. Swann AC, "Depression during mania. Treatment response to lithium or divalproex", Arch Gen Psychiatry, 54, pp.37~42 (1997)
47. Weisler RH, "SPD417 Study Group. A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes", J Clin Psychiatry, 65, pp.478~484 (2004)
48. Vieta E, "Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study", J Psychopharmacol, 24, pp.547~558 (2010)
49. Zhang ZJ, "Adjunctive herbal medicine with carbamazepine for bipolar disorders: A double-blind, randomized, placebo-controlled study", J Psychiatr Res, 41, pp.360~369 (2007)
50. Selle V, "Treatments for acute bipolar depression: meta-analyses of placebo-controlled, monotherapy trials of anticonvulsants, lithium and antipsychotics", Pharmacopsychiatry, 47, pp.43~52 (2014)
51. Judd LL, "The long-term natural history of the weekly symptomatic status of bipolar I disorder", Arch Gen Psychiatry, 59, pp.530~537 (2002)
52. Okuma T, "Comparison of the antimanic efficacy of carbamazepine and lithium carbonate by double-blind controlled study", Pharmacopsychiatry, 23, pp.143~150 (1990)
53. Small JG, "Carbamazepine compared with lithium in the treatment of mania", Arch Gen Psychiatry, 48, pp.915~921 (1991)
54. Rummel-Kluge C, "Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis", Schizophr Res, 123, pp.225~233 (2010)
55. de Bartolomeis A, "Combination of aripiprazole with mood stabilizers for the treatment of bipolar disorder: from acute mania to long-term maintenance", Expert Opin Pharmacother, 13, pp.2027~2036 (2012)
56. Pacchiarotti I, "The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders", Am J Psychiatry, 170, pp.1249~1262 (2013)
57. Montejo ÁL, "Multidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychotics", Front Neuroendocrinol, 45, pp.25~34 (2017)
58. Lorberg B, "Lamotrigine-associated rash: to rechallenge or not to rechallenge?", Int J Neuropsychopharmacol, 12, pp.257~265 (2009)
59. Seo HJ, "Safety and tolerability of lamotrigine: results from 12 placebo-controlled clinical trials and clinical implications", Clin Neuropharmacol, 34, pp.39~47 (2011)
60. Dols A, "Older age bipolar disorder", Psychiatr Clin North Am, 41, pp.95~110 (2018)
61. Chen P, "Update on the epidemiology, diagnosis, and treatment of mania in older-age bipolar disorder", Curr Psychiatry Rep, 19, pp.46~ (2017)
62. Orsolini L, "An update of safety of clinically used atypical antipsychotics", Expert Opin Drug Saf, 15, pp.1329~1347 (2016)
63. Stepanova E, "Psychopharmacology of bipolar disorders in children and adolescents", Pediatr Clin North Am, 6, pp.1209~1222 (2017)

관련 논문AI추천